Discovery of New Tuberculosis Drug Leads Targeting Cell Wall Biosynthesis.

Payne, Richard (Primary Chief Investigator (PCI))
Britton, Warwick (Chief Investigator (CI))
Crick, Dean (Chief Investigator (CI))
West, Nicholas P. (Chief Investigator (CI))
Charman, Susan (Chief Investigator (CI))

Centre for Drug Candidate Optimisation

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 31/12/17

Funding

National Health and Medical Research Council (NHMRC) (Australia): AUD75,416.00

1 Article

Sansanmycin natural product analogues as potent and selective anti-mycobacterials that inhibit lipid I biosynthesis
Tran, A. T., Watson, E. E., Pujari, V., Conroy, T., Dowman, L. J., Giltrap, A. M., Pang, A., Wong, W. R., Linington, R. G., Mahapatra, S., Saunders, J., Charman, S. A., West, N. P., Bugg, T. D. H., Tod, J., Dowson, C. G., Roper, D. I., Crick, D. C., Britton, W. J. & Payne, R. J., 1 Mar 2017, In: Nature Communications. 8, 9 p., 14414.
Research output: Contribution to journal › Article › Research › peer-review

File

24 Citations (Scopus)